65,437 trials
Sleep Deprivation
Primary: Functional Magnetic Resonance Imaging (fMRI)-Based Decoding Accuracy of Food vs Non-food Odors in Piriform Cortex — 54.38; 49.65 Percentage correctly classified — p=0.001
Malaria, Falciparum
Primary: Change in Haemoglobin Compared to the Baseline — 0.18; 0.54 g/dl
Pancreatic Masses · Lymph Nodes
Primary: Diagnostic Accuracy — 237; 263 Participants
Alcohol Use Disorder
Primary: Number of Participants Who Experienced Effective Electrode Placement — 17; 17 Participants
Indolent Plasma Cell Myeloma · Plasma Cell Myeloma · Smoldering Plasma Cell Myeloma
Primary: Number of Participants Experiencing a Dose-limiting Toxicity (DLT) — 0; 0; 0 Participants
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
Primary: Number of Participants With Grade 3 or 4 Thrombocytopenia Occurring Within 30 Days After Initial Administration of Niraparib — 6 Participants
Pulmonary Hypertension, Familial Persistent, of the Newborn
Primary: Time on Inhaled Nitric Oxide (iNO) Treatment After Initiation of Intravenous (IV) Study Drug For Participants Without Treatment Failure — 4.1; 4.1 days — p=0.9850
Osteoarthritis, Knee
Primary: Levels of Plasmin Anti-plasmin (PAP) - Marker of Fibrinolysis — 117.8; 1280.7; 1032; 1041.2 ug/L
Migraine
Primary: Pain-relief — 5.6; 5.1; 2.25; 2.2 units on a scale*hr
Healthy Adults
Primary: Concentration of Total Plasma Ketones — -18.2; 23; 12.2; 68.5 µmol/L
Hemophilia · Bone Disease
Primary: Bone Biomarker Density (BMD) — -0.74; -0.16; -0.16 Z-Score
Obstructive Sleep Apnea (OSA)
Primary: Polysomnography - Apnea-hypopnea Index (AHI) — 11.4; 0.7; 6; 1.1 units on a scale
Ventral Incisional Hernia
Primary: Difference in the Shear Wave Velocity Measurements in the Abdominal Wall Between Ventral Hernia and Healthy Abdominal Wall — 1.89; 1.92; 1.89 meters per second
Non-Hodgkin's Lymphoma
Primary: Phase I: Maximum-Tolerated Dose of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide (BOCE) — 120 mg/m^2
Sexually Transmitted Infections
Primary: Number of Subjects Who Had New Sexual Relationships — 56; 37; 61 Participants